GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Careplus Group Bhd (XKLS:0163) » Definitions » Debt-to-EBITDA

Careplus Group Bhd (XKLS:0163) Debt-to-EBITDA : -5.51 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Careplus Group Bhd Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Careplus Group Bhd's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was RM10.27 Mil. Careplus Group Bhd's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was RM31.27 Mil. Careplus Group Bhd's annualized EBITDA for the quarter that ended in Dec. 2023 was RM-7.54 Mil. Careplus Group Bhd's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -5.51.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Careplus Group Bhd's Debt-to-EBITDA or its related term are showing as below:

XKLS:0163' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.38   Med: 3.41   Max: 5.08
Current: -0.38

During the past 10 years, the highest Debt-to-EBITDA Ratio of Careplus Group Bhd was 5.08. The lowest was -0.38. And the median was 3.41.

XKLS:0163's Debt-to-EBITDA is ranked worse than
100% of 429 companies
in the Medical Devices & Instruments industry
Industry Median: 1.21 vs XKLS:0163: -0.38

Careplus Group Bhd Debt-to-EBITDA Historical Data

The historical data trend for Careplus Group Bhd's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Careplus Group Bhd Debt-to-EBITDA Chart

Careplus Group Bhd Annual Data
Trend Jan11 Jan12 Jan13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.51 3.25 3.36 4.91 0.18

Careplus Group Bhd Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.44 -0.88 -0.13 -3.25 -5.51

Competitive Comparison of Careplus Group Bhd's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, Careplus Group Bhd's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Careplus Group Bhd's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Careplus Group Bhd's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Careplus Group Bhd's Debt-to-EBITDA falls into.



Careplus Group Bhd Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Careplus Group Bhd's Debt-to-EBITDA for the fiscal year that ended in Dec. 2020 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(23.855 + 7.085) / 167.924
=0.18

Careplus Group Bhd's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(10.271 + 31.266) / -7.54
=-5.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Careplus Group Bhd  (XKLS:0163) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Careplus Group Bhd Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Careplus Group Bhd's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Careplus Group Bhd (XKLS:0163) Business Description

Traded in Other Exchanges
N/A
Address
Lot 17479, Lorong Senawang 3/2, Off Jalan Senawang 3, Senawang Industrial Estate, Seremban, NSN, MYS, 70450
Careplus Group Bhd is involved in the manufacturing, processing, and trading of gloves. The company's product consists of Latex exam gloves, Latex surgical gloves and Nitrile exam gloves. Its Latex exam gloves are used in the medical examinations and procedures, diagnostic procedures by the dentist, laboratory practices and for food handling practices. The Nitrile exam gloves are generally used in laboratory practices and the automotive industry. Geographically, it has operations in Central, North and South America, Malaysia, and the other Asia Pacific regions. It generates a vast majority of revenues from Other Asia Pacific and South America.

Careplus Group Bhd (XKLS:0163) Headlines

No Headlines